Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
04:15pm, Tuesday, 09'th Jul 2024
REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
08:30am, Friday, 28'th Jun 2024
REDWOOD CITY, Calif. , June 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic p
Nevro to Present at Truist Securities MedTech Conference
04:15pm, Tuesday, 11'th Jun 2024
REDWOOD CITY, Calif. , June 11, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic
Why Is Nevro (NVRO) Down 8.8% Since Last Earnings Report?
12:35pm, Thursday, 06'th Jun 2024
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain Nevro (NVRO) Stock for Now
01:40pm, Tuesday, 04'th Jun 2024
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
04:15pm, Friday, 24'th May 2024
REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pai
Nevro to Present at BofA Securities 2024 Healthcare Conference
04:05pm, Thursday, 09'th May 2024
REDWOOD CITY, Calif. , May 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain
Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up
01:16pm, Wednesday, 08'th May 2024
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
Nevro Corp. (NVRO) Q1 2024 Earnings Call Transcript
02:01am, Wednesday, 08'th May 2024
Nevro Corp. (NYSE:NVRO ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Angie McCabe - Vice President, Investor Relations & Corporate Communications Kevin Thornal - CEO a
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
06:31pm, Tuesday, 07'th May 2024
Nevro (NVRO) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to loss of $0.98 per share a year ago.
Nevro Reports First-Quarter 2024 Financial Results
04:05pm, Tuesday, 07'th May 2024
Announces Additional Restructuring Steps to Advance Strategy and Accelerate Profitability Raises Adjusted EBITDA Guidance and Reaffirms Revenue Guidance for Full-Year 2024 Promotes Christofer Christof
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
08:30am, Wednesday, 17'th Apr 2024
REDWOOD CITY, Calif. , April 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, tod
Here's Why You Should Retain Nevro (NVRO) Stock for Now
01:36pm, Thursday, 21'st Mar 2024
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
Nevro (NVRO) Gets FDA Nod for SI Fixation Without Lateral Screw
08:31am, Thursday, 29'th Feb 2024
Nevro's (NVRO) SI joint fusion device, Nevro1, gets FDA clearance for the use of a lateral screw NevroFix.
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
04:10pm, Wednesday, 28'th Feb 2024
Nevro1™ Proven to Immediately Transfix Sacroiliac (SI) Joint to Allow for Long-term SI Joint Fusion REDWOOD CITY, Calif. , Feb. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical d
